PMHNP Helper

ANCC- and AANPCB-style practice questions and interactive clinical case studies for psychiatric-mental health NPs.

Board Prep
ANCC Board PrepAANPCB Board PrepPractice QuestionsQuiz BuilderANCC BaselineAANPCB Baseline
Clinical
Case LibraryMedicationsDiagnosesDifferentialsFlashcards
Company
AboutPricingTerms of ServicePrivacy PolicyDisclaimer
This content is written for healthcare professionals and clinical learners. It is not intended as patient-facing medical advice. By using this site you agree to our Terms and Disclaimer.
PMHNP Helper
Practice QuestionsCase Library
MedicationsDiagnosesDifferentials
FlashcardsStudy Plan
PricingAbout
Practice QuestionsCase LibraryMedicationsDiagnosesDifferentialsFlashcardsStudy PlanPricingAbout
← First-Generation (Typical)
Antipsychotics · First-Generation (Typical)

Haloperidol

Brand: Haldol, Haldol Decanoate

First-generation (typical) antipsychotic, butyrophenone

7 cards

Want adaptive tracking?

Create a free account and every review is tracked with spaced repetition. Cards you struggle with come back sooner, and your weak areas surface automatically.

Create free account →

Card Topics

core (1)dosing (1)risk (2)monitoring (1)trap (2)

All Cards

1.Haloperidol: potency class and key clinical consequence.
2.Haloperidol IM dose for acute agitation.
3.Haloperidol IV: what cardiac risk requires ICU-level monitoring?
4.What should be screened for at every visit in a patient on chronic haloperidol?
5.Does haloperidol cause significant weight gain or metabolic syndrome?
6.A patient on haloperidol develops sustained fever, rigidity, and elevated CK. Despite being a 'typical' antipsychotic, can NMS still occur?
7.Haloperidol decanoate: dosing interval and key safety consideration.

Want the full clinical reference for this medication?

Read the Haloperidol reference page →